References
- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
- Laosombat V, Wongchanchailert M, Sattayasevana B, et al. Clinical and hematologic features of beta0-thalassemia (frameshift 41/42 mutation) in Thai patients. Haematologica. 2001;86(2):138–141.
- Thein SL. The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S35–S39.
- Winichagoon P, Fucharoen S, Thonglairoam V, et al. Beta-thalassemia in Thailand. Ann N Y Acad Sci. 1990;612:31–42.
- Fucharoen S, Winichagoon P. Thalassemia in SouthEast Asia: problems and strategy for prevention and control. Southeast Asian J Trop Med Public Health. 1992;23(4):647–655.
- Nopparatana C, Nopparatana C, Saechan V, et al. Prenatal diagnosis of α- and β-thalassemias in southern Thailand. Int J Hematol. 2020;111(2):284–292.
- Lynch JR, Brown JM, Best S, et al. Characterization of the breakpoint of a 3.5-kb deletion of the beta-globin gene. Genomics. 1991;10(2):509–511.
- Ou Z, Li Q, Liu W, et al. Elevated hemoglobin A2 as a marker for beta-thalassemia trait in pregnant women. Tohoku J Exp Med. 2011;223(3):223–226.
- Yamsri S, Sanchaisuriya K, Fucharoen G, et al. Genotype and phenotype characterizations in a large cohort of β-thalassemia heterozygote with different forms of α-thalassemia in northeast Thailand. Blood Cells Mol Dis. 2011;47(2):120–124.
- Pereira C, Relvas L, Bento C, et al. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin. Blood Cells Mol Dis. 2015;54(4):315–320.
- Gallienne AE, Dreau HM, Schuh A, et al. Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica. 2012;97(3):340–343.
- Tepakhan W, Yamsri S, Sanchaisuriya K, et al. Nine known and five novel mutations in the erythroid transcription factor KLF1 gene and phenotypic expression of fetal hemoglobin in hemoglobin E disorder. Blood Cells Mol Dis. 2016;59:85–91.
- Winichagoon P, Saechan V, Sripanich R, et al. Prenatal diagnosis of beta-thalassaemia by reverse dot-blot hybridization. Prenat Diagn. 1999;19(5):428–435.
- Tritipsombut J, Phylipsen M, Viprakasit V, et al. A single-tube multiplex gap-polymerase chain reaction for the detection of eight β-globin gene cluster deletions common in Southeast Asia. Hemoglobin. 2012;36(6):571–580.
- Tan AS, Quah TC, Low PS, et al. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia. Blood. 2001;98(1):250–251.
- Pakdee N, Yamsri S, Fucharoen G, et al. Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis. Blood Cells Mol Dis. 2014;53(1–2):11–15.
- Liu D, Zhang X, Yu L, et al. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia. Blood. 2014;124(5):803–811.
- Tepakhan W, Yamsri S, Fucharoen G, et al. Kruppel-like factor 1 mutations and expression of hemoglobins F and A2 in homozygous hemoglobin E syndrome. Ann Hematol. 2015;94(7):1093–1098.
- Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet. 2007;39(10):1197–1199.
- Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci U S A. 2008;105(33):11869–11874.
- Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet. 2001;2(4):245–255.
- Thein SL, Menzel S, Lathrop M, Garner C. Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Mol Genet. 2009;18(R2):R216–R223.
- Suzuki M, Yamazaki H, Mukai HY, et al. Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model. Mol Cell Biol. 2013;33(8):1687–1695.
- Jiang J, Best S, Menzel S, et al. cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood. 2006;108(3):1077–1083.
- Stadhouders R, Aktuna S, Thongjuea S, et al. HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. J Clin Invest. 2014;124(4):1699–1710.
- Weatherall DJ, Pembrey ME, Pritchard J. Fetal haemoglobin. Clin Haematol. 1974;3:467–508.
- Farrell JJ, Sherva RM, Chen ZY, et al. A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood. 2011;117(18):4935–4945.
- Xu J, Sankaran VG, Ni M, et al. Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 2010;24(8):783–798.
- Roy P, Bhattacharya G, Mandal A, et al. Influence of BCL11A, HBS1L-MYB, HBBP1 single nucleotide polymorphisms and the HBG2 XmnI polymorphism on Hb F levels. Hemoglobin. 2012;36(6):592–599.
- Nuinoon M, Makarasara W, Mushiroda T, et al. A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E. Hum Genet. 2010;127(3):303–314.
- Makani J, Menzel S, Nkya S, et al. Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood. 2011;117(4):1390–1392.
- Prayalaw P, Teawtrakul N, Jetsrisuparb A, et al. Phenotype and genotype in a cohort of 312 adult patients with nontransfusion-dependent thalassemia in Northeast Thailand. Acta Haematol. 2016;135(1):15–20.
- Menzel S, Thein SL. Genetic modifiers of fetal haemoglobin in sickle cell disease. Mol Diagn Ther. 2019;23(2):235–244.
- Zhou D, Liu K, Sun CW, et al. KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching. Nat Genet. 2010;42(9):742–744.
- Perseu L, Satta S, Moi P, et al. KLF1 gene mutations cause borderline HbA(2). Blood. 2011;118(16):4454–4458.
- Satta S, Paglietti ME, Sollaino MC, et al. Changes in HbA2 and HbF in alpha thalassemia carriers with KLF1 mutation. Blood Cells Mol Dis. 2017;64:30–32.
- Phanrahan P, Yamsri S, Teawtrakul N, et al. Molecular analysis of non-transfusion dependent thalassemia associated with Hemoglobin E-β-thalassemia disease without α-thalassemia. Mediterr J Hematol Infect Dis. 2019;11(1):e2019038.
- Sripichai O, Whitacre J, Munkongdee T, et al. Genetic analysis of candidate modifier polymorphisms in Hb E-beta 0-thalassemia patients. Ann N Y Acad Sci. 2005;1054:433–438.
- Lai Y, Zhou L, Yi S, et al. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients. Blood Cells Mol Dis. 2017;63:52–57.